** Shares of health insurer Oscar Health OSCR.N up 3.3% at
$17.8 premarket
** Co lifts FY revenue forecast to between $9 billion and
$9.1 billion, above prior view of $8.3 billion to $8.4 billion
** Analysts were expecting total full-year revenue of $8.7
billion - LSEG data
** OSCR expects annual selling, general and administrative
expenses to be lower than a year ago
** Co reports lower medical costs for second quarter
** OSCR posts Q2 medical loss ratio - the percentage of
premiums spent on medical care - of 79%, better than 79.9% for
the same period last year
** Co reports profit of 20 cents per share for the quarter
ended June 30, compared with a loss of 7 cents for Q2 2023
** As of last close, stock has nearly doubled YTD
(Reporting by Bhanvi Satija in Bengaluru)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))